GET THE PREMIUM SUBSCRIPTION FREE FOR 14 DAYS!

ACADIA Pharmaceuticals Inc. Stock Price (Quote) NASDAQ:ACAD

$27.42 ( 0.44% ) Friday, 11th Jun 2021

Range Low Price High Price Comment
30 days $20.62 $27.60 Friday, 11th Jun 2021 ACAD stock ended at $27.42. This is 0.44% more than the trading day before Thursday, 10th Jun 2021. During the day the stock fluctuated 2.56% from a day low at $26.91 to a day high of $27.60.
90 days $19.20 $30.16
52 weeks $19.20 $58.72

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2021-06-11 $27.09 $27.60 $26.91 $27.42 1 193 897
2021-06-10 $25.95 $27.34 $25.70 $27.30 1 681 508
2021-06-09 $26.73 $27.06 $25.62 $26.13 1 763 374
2021-06-08 $25.40 $26.63 $25.24 $26.57 1 982 973
2021-06-07 $23.72 $26.05 $23.65 $25.40 3 782 629
2021-06-04 $23.39 $23.72 $22.68 $23.69 1 385 368
2021-06-03 $22.56 $23.75 $22.21 $23.31 1 735 969
2021-06-02 $22.50 $22.98 $22.32 $22.62 1 333 440
2021-06-01 $22.51 $22.69 $21.77 $22.35 1 051 031
2021-05-28 $22.08 $22.73 $22.08 $22.34 1 013 262
2021-05-27 $21.85 $22.31 $21.60 $22.04 1 124 832
2021-05-26 $21.26 $21.76 $21.16 $21.71 1 171 415
2021-05-25 $21.34 $21.73 $21.24 $21.28 1 373 213
2021-05-24 $22.00 $22.09 $21.22 $21.32 1 269 693
2021-05-21 $21.59 $22.15 $21.41 $21.94 1 172 503
2021-05-20 $20.76 $21.67 $20.65 $21.58 1 261 537
2021-05-19 $21.24 $21.30 $20.62 $20.72 1 428 430
2021-05-18 $21.26 $21.97 $21.20 $21.39 2 187 815
2021-05-17 $21.51 $22.28 $21.02 $21.23 1 660 067
2021-05-14 $21.27 $21.94 $20.87 $21.77 1 364 927
2021-05-13 $21.85 $21.99 $20.93 $21.22 1 985 573
2021-05-12 $20.77 $22.33 $20.74 $21.83 2 298 760
2021-05-11 $20.65 $21.60 $20.36 $20.84 2 038 338
2021-05-10 $20.90 $21.27 $20.62 $21.02 1 317 313
2021-05-07 $20.89 $21.59 $20.65 $21.07 1 535 926
2021-05-06 $19.55 $20.99 $19.53 $20.95 2 696 803
2021-05-05 $19.42 $19.75 $19.20 $19.40 1 769 091
2021-05-04 $20.13 $20.23 $19.34 $19.52 2 501 953
2021-05-03 $20.54 $20.70 $20.21 $20.25 1 528 469
2021-04-30 $20.33 $20.79 $20.30 $20.56 1 264 892
2021-04-29 $20.94 $21.22 $20.43 $20.59 1 024 173
2021-04-28 $21.16 $21.18 $20.70 $20.77 1 395 126
2021-04-27 $21.31 $21.37 $20.83 $21.05 1 764 260
2021-04-26 $20.65 $21.65 $20.49 $21.35 1 717 815
2021-04-23 $20.85 $21.47 $20.49 $20.50 1 871 461
2021-04-22 $21.47 $21.74 $20.84 $20.87 1 944 462
2021-04-21 $20.82 $21.53 $20.68 $21.47 1 449 109
2021-04-20 $20.70 $21.25 $20.59 $20.80 1 448 226
2021-04-19 $21.04 $21.42 $20.24 $20.72 2 257 296
2021-04-16 $21.32 $21.40 $20.84 $21.15 4 776 098
2021-04-15 $21.34 $21.57 $21.03 $21.20 2 218 291
2021-04-14 $20.61 $21.78 $20.61 $21.28 2 838 454
2021-04-13 $20.50 $20.90 $20.42 $20.60 1 750 434
2021-04-12 $20.40 $20.71 $20.12 $20.43 2 021 343
2021-04-09 $20.78 $20.86 $20.31 $20.39 1 697 842
2021-04-08 $21.59 $21.60 $20.53 $20.68 2 742 901
2021-04-07 $20.39 $21.68 $20.37 $21.23 4 198 542
2021-04-06 $20.75 $21.18 $20.36 $20.64 7 938 469
2021-04-05 $21.25 $22.07 $20.92 $21.18 11 561 880
2021-04-01 $25.86 $26.28 $25.26 $25.59 1 498 949

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzh... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT